You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 706 BT7480, a fully synthetic tumor-targeted immune cell agonist (TICA™) induces tumor localized CD137 agonism and modulation of tumor immune microenvironment

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Novel single-agent immunotherapies
706 BT7480, a fully synthetic tumor-targeted immune cell agonist (TICA™) induces tumor localized CD137 agonism and modulation of tumor immune microenvironment

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020146015
Dec 20204008
Jan 20213709
Feb 20212208
Mar 202152013
Apr 202180016
May 202142012
Jun 2021008
Jul 2021008
Aug 2021006
Sep 2021009
Oct 202138024
Nov 202156030
Dec 20213404
Jan 202236013
Feb 20222004
Mar 20222506
Apr 20224804
May 20223805
Jun 20221603
Jul 20222902
Aug 20222808
Sep 20222201
Oct 20222003
Nov 20222404
Dec 20222200
Jan 20231400
Feb 20233001
Mar 20232803
Apr 20231803
May 20231801
Jun 20231606
Jul 20232604
Aug 20231403
Sep 2023601
Oct 20232805
Nov 20232405
Dec 20232802
Jan 2024400
Feb 20241600
Mar 20241601
Apr 20241600
May 20244002
Jun 20242000
Jul 20241601
Aug 20241800
Sep 20241202
Oct 20241607
Nov 20241403
Dec 2024605
Jan 20252007
Feb 2025001
Mar 20250010
Apr 2025002
May 20250011
Jun 2025003
Total13390312